About DPBIO Inc
DPBIO is a pioneering innovator based in California, specializing in high-throughput droplet microfluidic technology and providing cutting-edge life science solutions to researchers and industry leaders worldwide. At DPBIO, we integrate advanced microfluidic technology with life sciences to develop comprehensive solutions, including microfluidic chips, instruments, and reagents. Our flagship products—such as the CytoSpark® High-throughput Screening System, OMNIdrop System, Galaxy Single-Cell Analysis System, Nebula Digital PCR System, and ExoStar Extracellular Vesicle Analysis System—empower scientists in antibody discovery, enzyme evolution, strain screening, small-molecule drug screening, cancer research, early disease detection, viral quantification, and biopharmaceutical quality control. Trusted by leading biotech and pharmaceutical companies, top-tier research institutions, and clinical laboratories worldwide, DPBIO is committed to advancing life sciences with high-performance analytical and detection systems. Our mission is to accelerate drug discovery, synthetic biology, biomedical research, and precision medicine, driving breakthroughs that transform life science innovation.
